Universal Ibogaine advises of appointment of two new Board Members

Core Insights - Universal Ibogaine Inc. has appointed two new Directors, Nia Killebrew and Tony Wagner, to its Board effective August 28, 2025, filling a previously vacant position [1][2] - The Annual Meeting of Shareholders (AGM) is scheduled for September 4, 2025, where current Board member Dean Koumontzis will not stand for re-election [2] Company Overview - Universal Ibogaine Inc. is focused on transforming addiction treatment through medicalized ibogaine, with plans for a Canadian clinical trial targeting opioid use disorder [4] - The company is developing a holistic addiction treatment protocol at its Kelburn Recovery Centre, which aims to enhance the effectiveness of the ibogaine detox protocol [4]